Univest
Univest
  • Markets

Unichem Laboratories Share Price Jumps 13.5 Percent on 9 July 2026, Its Biggest Single Day Gain in 15 Months

  • July 9, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Unichem Laboratories Share Price Jumps 13.5 Percent on 9 July 2026

Unichem Laboratories share price Rs 649.95, up 13.49%. Hit fresh 52-week high Rs 687.20. Pending buy orders 56,834 shares, no sellers at open. Volume 10x five day average. Market cap Rs 4,829 crore.

The Unichem Laboratories share price surged 13.49 percent on 9 July 2026, marking its biggest single day gain in 15 months. The stock touched a fresh 52-week high of Rs 687.20, with pending buy orders of 56,834 shares and no sellers available for a stretch of the session.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Unichem Laboratories Share Price: Session Highlights
  • A Two Session Rally Approaching 35 Percent
  • What Investors Should Verify
  • Conclusion
  • Frequently Asked Questions FAQs
    • Why is the Unichem Laboratories share price rallying today?
    • What was the trading volume in Unichem Laboratories today?
    • Did Unichem Laboratories hit a new 52-week high?
    • What is Unichem Laboratories’ current market capitalisation?
    • Is there a specific trigger for the Unichem Laboratories rally?
    • What should investors do after such a sharp two day rally?

Unichem Laboratories Share Price: Session Highlights

Metric Value
Current price Rs 649.95, up 13.49 percent
52-week high touched Rs 687.20
Pending buy orders 56,834 shares, no sellers
Trading volume 468,051 shares vs 44,323 five day average
Volume increase 955.99 percent
Previous session gain 19.99 percent to Rs 571.65
Market capitalisation Rs 4,829 crore

Get Pharma Stock Guidance from SEBI Registered Investment Advisors

A Two Session Rally Approaching 35 Percent

The move on 9 July follows an equally sharp 19.99 percent gain in the previous session, meaning the Unichem Laboratories share price has risen close to 35 percent across just two trading days. The imbalance of pending buy orders with no sellers available signals strong conviction buying, while volumes nearly ten times the five day average confirm the scale of participation.

What Investors Should Verify

Moves of this magnitude are typically triggered by a specific corporate development such as a large order win, regulatory approval, or block deal. Investors should check the company’s latest exchange filings and news releases to identify the exact catalyst before making fresh investment decisions, given how far and fast the stock has already moved.

Download the Univest iOS App or Univest Android App to track the Unichem Laboratories share price and pharma sector news live.

Conclusion

The Unichem Laboratories share price rally, its steepest in 15 months, reflects a powerful wave of buying interest that has pushed the stock to a fresh 52-week high. With the move already close to 35 percent over two sessions, investors should size any fresh positions carefully and confirm the underlying trigger before chasing further strength.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions FAQs

Why is the Unichem Laboratories share price rallying today?

Ans. The Unichem Laboratories share price jumped 13.49 percent on 9 July 2026, its sharpest single day gain in 15 months, with the stock opening with a large pending buy order book of 56,834 shares and no sellers available.

What was the trading volume in Unichem Laboratories today?

Ans. The stock traded with volumes of 468,051 shares against its five day average of 44,323 shares, an increase of nearly 956 percent, pointing to unusually heavy participation.

Did Unichem Laboratories hit a new 52-week high?

Ans. Yes, the stock touched a fresh 52-week high of Rs 687.20 during the session, having also gained 19.99 percent in the previous trading session to close at Rs 571.65.

What is Unichem Laboratories’ current market capitalisation?

Ans. Unichem Laboratories has a market capitalisation of approximately Rs 4,829 crore as of the latest session.

Is there a specific trigger for the Unichem Laboratories rally?

Ans. The buy order imbalance and record volumes point to a strong positive catalyst, though investors should check the latest exchange filings and news releases from the company for the specific corporate development driving the move.

What should investors do after such a sharp two day rally?

Ans. After a near 34 percent two session gain, investors should review valuations, verify the underlying news, and consider that stocks with no sellers available can be volatile once selling pressure returns.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply